The pharmaceutical industry is routinely applauded for the R&D work they so diligently perform. This work not only creates jobs and plays an important role in our economy, but, more importantly, leads to improved medical care for all consumers. Things like cancer survival rates and overall quality of life improvements from chronic diseases are vastly improving because of this work. Most of the products that are brought to market have one thing in common: they are sold and stored in some form of container or package system. The type of packaging can play a key role in maintaining the effectiveness of the product. For example, a drug tablet that can be degraded by UV-Visible light must be stored in a container that prevents light from reaching the tablet. The United States Pharmacopeial Convention (USP), through its stated mission of “Improve global health through public standards and related programs that help ensure the quality, safety and benefits of medicines and foods” is responsible for guiding the industry to safe and effective product development. A Key part of the product development process is the container and package system that is used to deliver the product. On this front, the USP, as well as the Food and Drug Administration, has been behind the times. Finally, this is about to change.